Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane‐based regimens
The Journal of Dermatology · 2024
DOI: 10.1111/1346-8138.17101 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Dermatology, 2024. Verfasst von Shigeru Koizumi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan. Hauptthemen laut MEDLINE: Paget Disease, Extramammary, Antibodies, Monoclonal, Humanized, Mutation, Taxoids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
- Department of Dermatology, Chiba University, Chiba, Japan.
- Department of Pathology, Saitama Medical University International Medical Center, Saitama, Japan.
- Department of Dermatology, Toranomon Hospital, Tokyo, Japan.
ORCID-Profile: Shigeru Koizumi, Takashi Inozume
Zitieren
APA
Koizumi, S., Doi, R., Aitake, U., Lei, X., Izumi, T., Mori, T., Shojiguchi, N., Kawasaki, T., Inozume, T., & Kishi, A. (2024). Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane‐based regimens. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17101
Vancouver
Koizumi S, Doi R, Aitake U, Lei X, Izumi T, Mori T, et al. Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane‐based regimens. The Journal of Dermatology. 2024. doi:10.1111/1346-8138.17101
BibTeX
@article{Koizumi2024,
author = {Koizumi, Shigeru and Doi, Reiichi and Aitake, Urara and Lei, Xiaofeng and Izumi, Teruaki and Mori, Tatsuhiko and Shojiguchi, Naoko and Kawasaki, Tomonori and Inozume, Takashi and Kishi, Akiko},
title = {Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane‐based regimens},
journal = {The Journal of Dermatology},
year = {2024},
doi = {10.1111/1346-8138.17101}
}
EUVIMED